EcoDrugPlus

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSDORG00000012361
Gene Symbol: APH1B
3 Cross references
193 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSDORG00000001616
Gene Symbol: APEX1
4 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSDORG00000005528
Gene Symbol: ALOX12
4 Cross references
198 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSDORG00000003390
Gene Symbol: ALOX5
3 Cross references
223 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSDORG00000006041
Gene Symbol: ALOX5AP
4 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSDORG00000026784
Gene Symbol: AVPR1A
3 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSDORG00000013289
Gene Symbol: AVPR1B
4 Cross references
136 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSDORG00000002747
Gene Symbol: AVPR2
4 Cross references
251 Possible Orthologues:

Aromatase

Ensembl ID : ENSDORG00000009484
Gene Symbol: LOC105981070
4 Cross references
319 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSDORG00000007750
Gene Symbol: AHR
3 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSDORG00000008545
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSDORG00000009467
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).